Transdermal Skin Patches Market is Expected to Reach US$ 10.0 Billion by 2028, With a CAGR of 4.4% | IMARC Group

IMARC Group's report titled "Transdermal Skin Patches Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". The global transdermal skin patches market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.4% during 2023-2028.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/transdermal-skin-patches-market/requestsample

Factors Affecting the Growth of the Global Transdermal Skin Patches Industry:

• Advancements in Patch Technology and Formulations:

Continuous advancements in transdermal patch technology and formulations are improving their efficiency, further driving the demand. Additionally, several manufacturers are continually innovating to enhance the performance, safety, and versatility of transdermal patches. Apart from this, the emergence of personalized medicine is influencing the market positively. Researchers are exploring the potential to customize transdermal patches to deliver specific drug doses tailored to individual patient needs and optimize treatment efficacy while minimizing side effects. Furthermore, the integration of sensors and electronics into patches is enabling continuous health monitoring and data collection.

• Increasing Prevalence of Chronic Diseases:

The increasing prevalence of several chronic diseases, such as diabetes, hypertension, and chronic pain conditions is strengthening the growth of the market. Transdermal skin patches offer a convenient and effective way to deliver medications for chronic conditions. They provide a steady and controlled release of drugs through the skin into the bloodstream, ensuring consistent therapeutic levels. Additionally, the rising preferences of individuals for transdermal patches over traditional oral medications are driving the market. Transdermal skin patches offer reduced risk of side effects, eliminate the need for daily injections, and enhance medication adherence.

• Escalating Demand for Pain Management Solutions:

The rising demand for effective pain management solutions is supporting the growth of the market. Additionally, the increasing prevalence of chronic pain conditions, such as arthritis, neuropathic pain, and musculoskeletal disorders is driving the demand for transdermal skin patches as they provide a consistent and controlled release of analgesic medications, ensuring prolonged pain relief without the need for frequent dosing. Along with this, the expanding elderly population, which is more susceptible to adverse drug reactions and interactions is offering a favorable market outlook. Transdermal patches can help mitigate these risks by providing a controlled and steady release of medications, reducing the chances of overmedication or undermedication.

Leading Companies Operating in the Global Transdermal Skin Patches Industry:

• 3M Company
• AdhexPharma
• LTS Lohmann Therapie-Systeme AG
• Luye Pharma Group
• Medherant Limited
• Nitto Denko Corporation
• Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
• Prosolus Inc.
• Samyang Holdings Corporation
• Tapemark
• Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
• tesa SE (Beiersdorf AG)
• Teva Pharmaceutical Industries Ltd.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: : https://www.imarcgroup.com/transdermal-skin-patches-market

Global Transdermal Skin Patches Market Report Segmentation:

By Type:

• Single-layer Drug-in-Adhesive
• Multi-layer Drug-in-Adhesive
• Matrix
• Others

Matrix dominates the market due to its versatility, ease of formulation, and wide-ranging applicability to deliver various medications effectively.

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Stores

On the basis of the distribution channel, the market has been segmented into hospital pharmacies, retail pharmacies, and online stores.

By Application:

• Pain Relief
• Smoking Reduction and Cessation Aid
• Overactive Bladder
• Hormonal Therapy
• Others

Pain relief represents the largest market segment due to the increasing demand for non-invasive, long-lasting solutions to manage various types of pain, from chronic conditions to acute discomfort.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America's dominance in the transdermal skin patches market is attributed to its robust healthcare infrastructure, high prevalence of chronic diseases, and the escalating demand for convenient and non-invasive drug delivery methods.

Global Transdermal Skin Patches Market Trends:

The increasing utilization of transdermal skin patches in smoking cessation and nicotine replacement therapy (NRT) programs to reduce smoking rates and combat tobacco-related health issues is influencing the market positively. Smoking cessation patches offer a gradual reduction in nicotine intake, making the process more manageable for users and increasing the likelihood of long-term success. Additionally, the rise in government initiatives, public health campaigns, and awareness about the health risks associated with smoking are catalyzing the demand for NRT products, including transdermal patches.

Browse More Reports:

Technical Foam Market : https://www.linkedin.com/pulse/exploring-future-growth-technical-foam-market-report-vik-chauhan-bxsqc/
Water Enhancer Market : https://www.linkedin.com/pulse/water-enhancer-market-share-analysis-report-2023-2028-vik-chauhan-hv1jc/
Artificial Cornea and Corneal Implant Market : https://www.linkedin.com/pulse/artificial-cornea-corneal-implant-market-growth-drivers-vik-chauhan-dzgjc/

Contact Us:

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.